We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
226
Axsome Therapeutics
AXSM
$10.8B
$1.41M 0.03%
15,666
+548
+4% +$47.8K
ALKS icon
227
Alkermes
ALKS
$8.11B
$1.4M 0.03%
49,961
-27,039
-35% -$721K
VERA icon
228
Vera Therapeutics
VERA
$2.3B
$1.39M 0.03%
31,452
-7,964
-20% -$302K
ALGN icon
229
Align Technology
ALGN
$12B
$1.39M 0.03%
5,450
+3,416
+168% +$806K
ADSK icon
230
Autodesk
ADSK
$51.2B
$1.38M 0.03%
+5,000
New +$1.26M
CRM icon
231
Salesforce
CRM
$153B
$1.37M 0.03%
5,000
-15,000
-75% -$3.84M
ATXS
232
DELISTED
Astria Therapeutics
ATXS
$1.37M 0.03%
124,202
+11,537
+10% +$128K
PPLI
233
People Inc
PPLI
$3.2B
$1.35M 0.03%
30,475
-3,048
-9% -$127K
RH icon
234
RH
RH
$3.56B
$1.34M 0.03%
+4,000
New +$1.1M
LRMR icon
235
Larimar Therapeutics
LRMR
$436M
$1.33M 0.03%
202,783
-5,000
-2% -$40.2K
OFIX icon
236
Orthofix Medical
OFIX
$432M
$1.33M 0.03%
84,883
+7,885
+10% +$126K
LBPH
237
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.31M 0.03%
39,260
-12,336
-24% -$425K
VSTM icon
238
Verastem
VSTM
$519M
$1.29M 0.03%
430,669
+330,280
+329% +$896K
ITCI
239
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.27M 0.03%
17,343
+343
+2% +$25.8K
TMCI icon
240
Treace Medical Concepts
TMCI
$284M
$1.26M 0.03%
217,755
+4,779
+2% +$30.7K
CRNX icon
241
Crinetics Pharmaceuticals
CRNX
$8.9B
$1.26M 0.03%
24,693
-428
-2% -$22.1K
CAPR icon
242
Capricor Therapeutics
CAPR
$242M
$1.26M 0.03%
+82,900
New +$410K
GTY
243
Getty Realty Corp
GTY
$2.06B
$1.26M 0.03%
39,582
-18,846
-32% -$577K
PLD icon
244
Prologis
PLD
$132B
$1.25M 0.03%
9,868
-5,411
-35% -$671K
AEO icon
245
American Eagle Outfitters
AEO
$2.97B
$1.23M 0.03%
55,000
-55,000
-50% -$1.13M
IFRX icon
246
InflaRx
IFRX
$253M
$1.22M 0.03%
797,876
+76,108
+11% +$116K
ALC icon
247
Alcon
ALC
$33.9B
$1.2M 0.03%
12,009
-245
-2% -$23K
INZY
248
DELISTED
Inozyme Pharma
INZY
$1.18M 0.03%
226,232
+21,014
+10% +$109K
RARE icon
249
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.18M 0.03%
21,269
-13,859
-39% -$706K
STRO icon
250
Sutro Biopharma
STRO
$400M
$1.17M 0.03%
33,822
+6,316
+23% +$248K
8 9
10
11 12

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.